HAL vs RIGL
Halliburton Company (HAL) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the HAL and RIGL stock pages for the full models.
Not investment advice.